Within GLP-1 RAs, are there comparative distinctions--dosing, PK/PD, side effects, weight loss, lipid profiles, and BP--that have clinical relevance that should be highlighted? How do they differentially affect PPG?

Within GLP-1 RAs, are there comparative distinctions--dosing, PK/PD, side effects, weight loss, lipid profiles, and BP--that have clinical relevance that should be highlighted? How do they differentially affect PPG?

Within the class of GLP-1 RAs, are there important comparative distinctions—dosing, PK/PD, side effects, weight loss, lipid profiles, and BP—that have clinical relevance that you believe should be highlighted? How do they differentially affect PPG?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Ralph DeFronzo, MD

Ralph DeFronzo, MD

Professor of Medicine Chief of the Diabetes Division The University of Texas Health Science Center at San Antonio San Antonio, Texas